Total Payments
$3,893
2024 Payments
$1,061
Companies
29
Transactions
236
Medicare Patients
2,256
Medicare Billing
$297,657
Payment Breakdown by Category
Food & Beverage$3,809 (97.8%)
Education$84.00 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,809 | 233 | 97.8% |
| Education | $84.00 | 1 | 2.2% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
General
$3,893
234 transactions
Ownership
$0
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $720.80 | 56 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $489.86 | 27 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $387.89 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $335.48 | 15 | $0 (2024) |
| Allergan, Inc. | $268.27 | 18 | $0 (2020) |
| Celgene Corporation | $225.60 | 10 | $0 (2024) |
| GENZYME CORPORATION | $184.70 | 7 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $142.48 | 12 | $0 (2017) |
| Takeda Pharmaceuticals America, Inc. | $137.26 | 10 | $0 (2017) |
| Intercept Pharmaceuticals, Inc. | $131.08 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,061 | 52 | ABBVIE INC. ($229.73) |
| 2023 | $864.99 | 54 | AbbVie Inc. ($214.90) |
| 2022 | $391.48 | 18 | Celgene Corporation ($103.53) |
| 2020 | $89.01 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($20.72) |
| 2019 | $555.27 | 35 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($185.66) |
| 2018 | $362.63 | 26 | Allergan Inc. ($69.71) |
| 2017 | $569.19 | 45 | Valeant Pharmaceuticals North America LLC ($142.48) |
All Payment Transactions
236 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Immunology | ||||||
| 10/26/2024 | PFIZER INC. | XELJANZ (Drug), INFLECTRA, ABRILADA | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/24/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: LIVER DISEASE | ||||||
| 10/21/2024 | PFIZER INC. | XELJANZ (Drug), INFLECTRA, ABRILADA | Food and Beverage | In-kind items and services | $35.51 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/16/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: GI COLON PREP | ||||||
| 09/17/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.91 | General |
| Category: GI | ||||||
| 09/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.13 | General |
| Category: Gastroenterology | ||||||
| 09/05/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Immunology | ||||||
| 08/19/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $36.97 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/31/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/18/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Immunology | ||||||
| 07/11/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 07/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.28 | General |
| 07/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/19/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $84.00 | General |
| Category: Immunology | ||||||
| 06/06/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/30/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Gastroenterology | ||||||
| 05/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.69 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 571 | 607 | $514,447 | $75,055 |
| 2022 | 12 | 575 | 613 | $480,265 | $75,292 |
| 2021 | 14 | 594 | 683 | $406,571 | $82,060 |
| 2020 | 12 | 516 | 589 | $307,655 | $65,249 |
Total Patients
2,256
Total Services
2,492
Medicare Billing
$297,657
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 162 | 162 | $234,689 | $32,090 | 13.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 100 | $25,300 | $8,735 | 34.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 39 | 39 | $40,541 | $7,508 | 18.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 32 | 32 | $33,264 | $6,076 | 18.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 73 | 76 | $62,282 | $6,021 | 9.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $9,900 | $3,298 | 33.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 39 | 39 | $45,903 | $3,156 | 6.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $23,909 | $2,998 | 12.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $5,544 | $1,870 | 33.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 27 | $4,158 | $1,787 | 43.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $11,616 | $1,332 | 11.5% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $16,374 | $173.75 | 1.1% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 13 | 22 | $968.00 | $11.21 | 1.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 135 | 135 | $192,282 | $26,497 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 127 | $31,441 | $11,549 | 36.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 40 | 40 | $40,730 | $7,621 | 18.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 76 | 76 | $61,165 | $6,193 | 10.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 27 | 27 | $27,972 | $5,287 | 18.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 58 | 58 | $67,089 | $5,260 | 7.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 33 | 33 | $9,912 | $3,597 | 36.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 37 | 37 | $8,955 | $3,185 | 35.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $19,278 | $2,922 | 15.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 24 | 25 | $17,952 | $2,154 | 12.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 18 | $2,702 | $1,016 | 37.6% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2022 | 12 | 18 | $788.00 | $9.56 | 1.2% |
About Dr. William Coll, MD
Dr. William Coll, MD is a Gastroenterology healthcare provider based in Torrington, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275526469.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Coll, MD has received a total of $3,893 in payments from pharmaceutical and medical device companies, with $1,061 received in 2024. These payments were reported across 236 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,809).
As a Medicare-enrolled provider, Coll has provided services to 2,256 Medicare beneficiaries, totaling 2,492 services with total Medicare billing of $297,657. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Torrington, CT
- Active Since 08/24/2005
- Last Updated 02/10/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1275526469
Products in Payments
- XIFAXAN (Drug) $423.81
- STELARA (Biological) $312.23
- LINZESS (Drug) $301.83
- ENTYVIO (Biological) $230.28
- ZEPOSIA (Drug) $225.60
- CREON (Drug) $224.79
- DUPIXENT (Biological) $184.70
- Entyvio (Biological) $135.39
- OCALIVA (Drug) $131.08
- Humira (Biological) $126.62
- RINVOQ (Biological) $114.75
- VIBERZI (Drug) $111.66
- SUCRAID (Drug) $101.57
- Amitiza (Drug) $92.20
- XELJANZ (Drug) $86.70
- UCERIS (Drug) $86.05
- XIFAXANIBSD (Drug) $79.28
- SKYRIZI (Biological) $70.17
- GATTEX (Drug) $57.45
- REBYOTA (Biological) $55.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Torrington
Dr. Michael Disiena, M.d, M.D
Gastroenterology — Payments: $32,630
Gastroenterology $32,630
Joseph Scirica, Md, MD
Gastroenterology — Payments: $4,616
Gastroenterology $4,616
Michelle Tong
Gastroenterology — Payments: $3,826
Gastroenterology $3,826
Robert Lindenberg, Md, MD
Gastroenterology — Payments: $2,960
Gastroenterology $2,960
Mrs. Angela Murno, Aprn Bc, APRN BC
Gastroenterology — Payments: $2,623
Gastroenterology $2,623
Leslie Goldman, Md, MD
Gastroenterology — Payments: $2,015
Gastroenterology $2,015